[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555627":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":23,"locations":33,"responsibleParty":50,"collaborators":54,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":22,"enrollmentInfo":68,"targetDuration":22,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":22,"overallStatus":36,"whyStopped":22,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Hennepin Healthcare Research Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Pneumococcal Vaccination","EXPERIMENTAL","All participants will receive a pneumococcal vaccine.",[13],"Biological: Conjugate Pneumococcal Vaccine 20 (PCV20)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","Conjugate Pneumococcal Vaccine 20 (PCV20)","Vaccine",[9],[21],"Prevnar20",null,[24,29],{"name":25,"role":26,"phone":27,"phoneExt":22,"email":28},"Anne Frosch, MD","CONTACT","(612)-283-4349","Anne.Frosch@hcmed.org",{"name":30,"role":26,"phone":31,"phoneExt":22,"email":32},"Marya Abd El Hadi, BSc","(612)-873-6252","MAbdElHadi@hhrinstitute.org",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Hennepin Healthcare System","RECRUITING","Minneapolis","Minnesota","55415","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-93.26384,44.97997,{"lat":46,"lon":45},[49],{"name":25,"role":26,"phone":22,"phoneExt":22,"email":22},{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":22,"oldOrganization":22},"PRINCIPAL_INVESTIGATOR","Anne Frosch","Principal Investigator",[55],{"name":56,"class":57},"National Institute on Aging (NIA)","NIH","100555627","phase-4-vaccine-immunity-and-inflammation-in-the-aging-person-living-with-hiv-100555627",false,"NCT06514547","Vaccine Immunity and Inflammation in the Aging Person Living With HIV","VIVID","Inclusion Criteria:\n\n* Age\\>=18 years\n* HIV Diagnosis\n* On Antiretroviral Therapy with HIV Viral Load\\\u003C200 within last year\n\nExclusion Criteria:\n\n* Other significant immunosuppressing condition\n* Age\\\u003C 18 years\n* Pregnancy (at enrollment)\n* Contraindication to pneumococcal vaccination\n* Known contraindication to non-clinical blood draws (severe anemia last hemoglobin \\\u003C8g\u002Fdl)\n* Subjects who, in the opinion of the Investigator, may be non-adherent to study schedules or procedures.\n* Adults unable to consent\n* Individuals with impaired ability to consent\n* Incarceration at time of enrollment\n\nControls inclusion criteria:\n\n* Age\\>=18 years\n* HIV Ag-Ab test negative",true,"ALL","18 Years",{"count":69,"type":70},250,"ESTIMATED","INTERVENTIONAL",[73],"PHASE4","This study will track immune responsiveness to conjugate pneumococcal vaccines over time to help determine how long protection from this vaccine lasts in individuals with chronic medical conditions (in this study - HIV) and with age.",[76,77],"HIV Infections","Age","2025-06-09",{"date":80,"type":81},"2025-06-12","ACTUAL",{"date":83,"type":81},"2024-07-08",{"date":85,"type":70},"2029-06-30",{"name":5,"class":6},1]